Product Images Rezurock
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Rezurock NDC 79802-200 by Kadmon Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - image 01
Principal Display Panel - Bottle Label - image 02
This text describes the medication REZUROCK, which is available in tablet form containing 200 mg of belumosudil (equivalent to 242.50mg of belumosudil mesylate). The recommended dosage of REZUROCK is not listed, and users should refer to the prescribing information. The tablets should be swallowed whole and should not be chewed, cut, or crushed. The medication should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The container should remain in the original packaging with the desiccant to protect it from moisture, and it should be kept away from children. The medication is distributed by Kadmon Pharmaceuticals, LLC, and manufactured by UPM Pharmaceuticals in Bristol, TN, and the active ingredient is made in India. The LOT and EXP are not available in the given text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.